A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Condition: Hypertension · Sponsor: Novartis Pharmaceuticals
About this study
The purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients with mild to moderate hypertension
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (80)
| SEC Clinical Research LLC | Andalusia, Alabama, United States | — |
| UAB St Vincents | Birmingham, Alabama, United States | — |
| Longwood Research | Huntsville, Alabama, United States | — |
| The Center for Clinical Trials | Saraland, Alabama, United States | — |
| Elite Clinical Studies | Phoenix, Arizona, United States | — |
| Synexus Clinical Research US Inc | Tucson, Arizona, United States | — |
| NICRs Research Center | Garden Grove, California, United States | — |
| Valiance Clinical Research | Huntington Park, California, United States | — |
| Downtown L A Research Center Inc | Los Angeles, California, United States | — |
| Clinical Trials Research Sacramento | Sacramento, California, United States | — |
| Encompass Clinical Research | Spring Valley, California, United States | — |
| Clinical Research of Brandon LLC | Brandon, Florida, United States | — |
+ 68 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06857955